Migvis Monduy, MD

Los profesionales de salud identificados con el logotipo de Nicklaus Children's Pediatric Specialists son afiliados de Nicklaus Children’s Health System. Todos los demás en este sitio web tienen prácticas médicas independientes.

 Migvis Monduy, MD 
Medical Director, Neuromuscular and Movement Disorders Programs 
Dr. Migvis Monduy is a pediatric neurologist and serves as medical director of the Neuromuscular and Movement Disorders Programs with Nicklaus Children’s Hospital. She earned her medical degree from the University of South Florida Morsani College of Medicine in Tampa. Dr. Monduy completed a residency in pediatric neurology at Baylor College of Medicine/Texas Children’s Hospital in Houston. Her clinical interests include neuromuscular disorders, movement disorders and brain injury medicine.
Dr. Monduy is board certified in neurology with special qualifications in child neurology and brain injury medicine. She is a member of the Child Neurology Society, American Academy of Neurology, International Parkinson and Movement Disorder Society, along with the American Academy of Cerebral Palsy and Developmental Medicine. Dr. Monduy also serves as a peer reviewer for Frontiers in Pediatrics, Muscle and Nerve, as well as the Journal of Child Neurology. Her work has been published in peer-reviewed journals and she has presented at medical conferences.  
Dr. Monduy is employed by Nicklaus Children’s Pediatric Specialists (NCPS), the multispecialty medical group practice of Nicklaus Children’s Health System. She is bilingual in English and Spanish.  

Founded in 2001, Nicklaus Children’s Hospital’s Brain Institute is one of the largest comprehensive pediatric programs dedicated solely to the care of the developing brain. It brings together world-renowned specialists in numerous pediatric neuroscience subspecialties with cumulative clinical experience unparalleled in the United States. Since 2008, the program has been ranked among the nation’s top-tier programs for pediatric neurology and neurosurgery by U.S. News & World Report. The clinical and research leadership of the program serves as a beacon to families confronting the uncertainty of a child with a brain disorder, offering the latest treatments and assessment techniques, many of which were developed by the Brain Institute team. 

Chiriboga, C.A., Bruno, C., Duong, T., et al (2023). Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study. Neurology and therapy, 12 (2), 543-557. View in Pubmed

Guglieri, M., Clemens, P.R., …, Monduy, M., et al (2022). Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial. JAMA neurology, 79(10), 1005-1014. View in Pubmed

Klopstock, T., Videnovic, A. ..., Monduy, M., et al (2021). Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration. Movement disorders, 36(6), 1342-1352. View in Pubmed

Oficina Principal

Nicklaus Children's Pediatric Specialists - Neurology
3200 SW 60 Court #302
Miami, FL 33155
Número de Teléfono:


Fellowship - Texas Children's Hospital
Residency - Texas Children's Hospital
Medical School - University of South Florida


American Board of Psychiatry & Neurology (Child Neur) - Certified
American Board of Psychiatry & Neurology (Brain Injury) - Certified